[27PS2-pm] Therapeutic drug monitoring (TDM) and administration plans/Pharmacotherapies (Personalized therapies)

Mon. Mar 27, 2023 1:50 PM - 3:26 PM [Room PS2] (1F)

Chair: Hisakazu Ohtani, Yumiko Akamine

+Add all to schedule

1:50 PM - 2:02 PM

[27PS2-pm01S] Population pharmacokinetic analysis of sildenafil for enteral and oral administration in pediatric patients with pulmonary arterial hypertension

○Keisuke Shikasho¹, Huiyi Hu¹, Kenji Okada¹, Takeshi Ikegawa², Takuya Wakamiya², Reiko Iwano³, Takashi Yoshikado¹, Mikako Oka¹, Hideaki Ueda², Koji Chiba¹ (1. Yokohama Univ. of Pharm., 2. Department of Cardiology, Kanagawa Children’s Med. Center, Kanagawa, Japan, 3. Clinical Research Inst., Kanagawa Children’s Med. Center, Kanagawa, Japan)

2:02 PM - 2:14 PM

[27PS2-pm02S] The trends for implementation of loading dose and exploration of factors affecting 30-day mortality in teicoplanin: A Japanese administrative claims database study

○Moeno Ichii¹, Ryota Goto¹, Ryo Inose¹, Yuichi Muraki¹ (1. Kyoto Pharmaceutical University)

2:14 PM - 2:26 PM

[27PS2-pm03S] Evaluation for the effect of pharmacist interventions on appropriate use of voriconazole: A Japanese administrative claims database study

○Misato Shimoki¹, Ryota Goto¹, Ryo Inose¹, Moeno Ichii¹, Saki Ito¹, Yuichi Muraki¹ (1. Kyoto Pharmaceutical University)

2:26 PM - 2:38 PM

[27PS2-pm04S] A novel parameter-based prediction model for serum free valproic acid concentration

○Takahiro Asakawa¹, Masayuki Ishikawa^1,2, Masashi Uchida^1,2, Shota Suzuki², Shingo Yamazaki², Yuki Shiko³, Yohei Kawasaki³, Takaaki Suzuki^1,2, Itsuko Ishii^1,2, Yuko Sekine¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Div. Pharm., Chiba Univ. Hosp., 3. Clin. Res. Ctr., Chiba Univ. Hosp.)

2:38 PM - 2:50 PM

[27PS2-pm05S] Initial dosage of pediatrics treated vancomycin using trough concentration for therapeutic index with antimicrobial TDM clinical guideline .

○Manatsu Kawabe¹, Hiroaki Yoshida², Hiroaki Tanaka², Haruka Ohashi², Fumie Yamaguchi², Daichi Yamaguchi¹, Yasuhiro Tsuji¹, Yoshifumi Nishi¹ (1. Sch. Pharm., Nihon Univ., 2. Dept. Pharm., Kyorin Univ.,Sch. Med.)

2:50 PM - 3:02 PM

[27PS2-pm06S] Plasma concentrations of osimertinib and treatment progress in patients with non-small cell lung cancer

○Sae Nakahara¹, Nao Komizo¹, Mizuki Yamazaki^1,2, Chisato Nanba¹, Chiemi Hirose², Hirotoshi Iihara^1,2, Yuto Yamada^1,2, Komei Yanase³, Yasushi Ohno³, Kenichiro Todoroki⁴, Shuji Yamashita¹, Akio Suzuki^1,2, Hideki Hayashi^1,2 (1. Gifu Pharm. Univ., 2. Dpt. of Pharm., Gifu Univ. Hosp., 3. Dpt. of Respir. Med., Gifu Univ. Hosp., 4. Sch. of Pharm. Sci., Univ. of Shizuoka)

3:02 PM - 3:14 PM

[27PS2-pm07S] Physiologically-based pharmacokinetic modeling of arbekacin for individualized dosing

○Yosuke Kobayashi¹, Keiji Okada¹, Takashi Yoshikado¹, Mikako Oka¹, Koji Chiba¹ (1. Yokohama Univ. Pharm.)

3:14 PM - 3:26 PM

[27PS2-pm08S] Risk factor analysis of vancomycin-induced nephrotoxicity in paediatric patients aged 0 - 1 year using Japanese medical database

○Takayuki Miyai¹, Yoh Takekuma², Hitoshi Kashiwagi³, Yuki Sato³, Shunsuke Nashimoto³, Mitsuru Sugawara^2,3, Shungo Imai^3,4 (1. Grad. Sch. Life Sci., Hokkaido Univ., 2. Dept. Pharm., Hokkaido Univ. Hosp. , 3. Fac. Pharm. Sci., Hokkaido Univ., 4. Keio Univ. Pharm.)

Session information